149
Participants
Start Date
February 20, 2018
Primary Completion Date
July 25, 2019
Study Completion Date
July 25, 2019
AS03
AS03 oil-in-water emulsion adjuvant.
Inactivated influenza H7N9 vaccine
Monovalent 2017 H7N9 inactivated influenza vaccine
Influenza Virus Quadrivalent Inactivated Vaccine
A seasonal quadrivalent inactivated influenza vaccine (IIV4), prepared from influenza viruses propagated in embryonated chicken eggs, protecting against 2 influenza A subtypes (H1N1 and H3N2) and 2 influenza B subtypes (B Yamata lineage and B Victoria lineage).
Phosphate Buffered Saline (PBS) diluent
Diluent for Adjuvanted 2017 Monovalent Inactivated Influenza A/H7N9 vaccine (2017 H7N9IIV)
University of Alabama at Birmingham School of Medicine - Alabama Vaccine Research Clinic, Birmingham
University of Maryland School of Medicine - Center for Vaccine Development - Baltimore, Baltimore
Cincinnati Children's Hospital Medical Center - Infectious Diseases, Cincinnati
Vanderbilt University Medical Center - Infectious Diseases, Nashville
National Institute of Allergy and Infectious Diseases (NIAID)
NIH